Drug
AR 105
AR 105: highest development phase Phase 2, developed by Aridis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Aridis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AR-105 NCT03027609 | Phase 2 | Pseudomonas Aeruginosa Pneumonia |
Latest
No recent events.
Follow AR 105 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.